Quest Diagnostics Inc. vs. Natera, Inc. Common Stock
Quest Diagnostics Inc. (DGX) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| DGX | NTRA | |
|---|---|---|
| Market Cap | $27.31 billion | $52.80 billion |
| Revenue (TTM) | $11.56 billion | $2.71 billion |
| Net Income (TTM) | $1.11 billion | $-192,346,000 |
DGX leads on 2 of 3 size & scale factors.
Valuation
| DGX | NTRA | |
|---|---|---|
| P/E Ratio | 26.16 | — |
| Price / Book | 3.49 | 28.99 |
| Price / Sales | 2.36 | 19.50 |
DGX leads on 2 of 2 valuation factors.
Profitability
| DGX | NTRA | |
|---|---|---|
| Net Margin | 9.63% | -7.11% |
| Return on Equity | 14.23% | -10.56% |
DGX leads on 2 of 2 profitability factors.
Dividend
| DGX | NTRA | |
|---|---|---|
| Dividend Yield | 1.40% | — |
| Payout Ratio | 36.52 | — |
DGX and NTRA split the dividend factors evenly.
Risk & Sentiment
| DGX | NTRA | |
|---|---|---|
| Short Interest | 4.76% | 0.96% |
NTRA leads on 1 of 1 risk & sentiment factors.
Dig deeper: DGX overview, DGX financials, NTRA overview, NTRA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.